Obstructive sleep apnoea syndrome in patients living with diabetes: Which patients should be screened?
Fiche publication
Date publication
avril 2019
Journal
Diabetes & metabolism
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOHME Philip
Tous les auteurs :
Borel AL, Tamisier R, Böhme P, Priou P, Avignon A, Benhamou PY, Hanaire H, Pépin JL, Kessler L, Valensi P, Darmon P, Gagnadoux F
Lien Pubmed
Résumé
Because type 2 diabetes (T2D) is related to obesity, it is often associated with obstructive sleep apnoea syndrome (OSAS), although OSAS is also frequently diagnosed in patients with type 1 diabetes (T1D) and may promote gestational diabetes. Thus, this systematic review of the scientific evidence aimed to evaluate the epidemiological association between OSAS and all forms of diabetes, the current understanding of the pathophysiological mechanisms behind these associations, the expected benefits and limitations of OSAS treatment in patients with diabetes and, finally, to propose which patients require screening for OSAS.
Mots clés
Continuous positive airway pressure, Obstructive sleep apnoea syndrome, Screening, Treatment, Type 1 diabetes, Type 2 diabetes
Référence
Diabetes Metab. 2019 04;45(2):91-101